India Animal Vaccine Market By Animal Type (Livestock, Swine, Poultry, Companion Animals, Others), By Technology (Inactive Vaccine, Live Attenuated Vaccine, Toxoid Vaccine, Recombinant Vaccine, Others), By Disease (Foot and Mouth Disease, New Castle Disease, Infectious Bronchitis, Infectious Bursal Disease, Fowl pox, Rabies, Others), By Route of Administration (Subcutaneous, Intramuscular, Intraocular, Oral, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Animal Vaccine Market was valued at USD 245.48 Million in 2024 and is anticipated to reach USD 330.59 Million by 2030, with a CAGR of 5.19% during 2025-2030. 

This vital industry focuses on the research, production, and distribution of vaccines that protect animal health. These veterinary biologics are indispensable for safeguarding both livestock and companion animals, playing a crucial role in preventing infectious disease outbreaks and ensuring the well-being of India's diverse animal populations.

Key Market Drivers

Rising Livestock Disease Incidence

• The rising incidence and continued threat of livestock diseases is a major growth driver for the India animal vaccines market because the country’s large, dense, and widely dispersed animal population creates persistent risk of rapid disease transmission across farms, mandis, transport routes, and supply chains.

• Preventive vaccination is becoming more important because it is often more practical and cost-effective than depending only on treatment after outbreaks emerge. This is especially relevant in India, where animal health directly influences milk production, meat output, egg supply, farm productivity, and rural household income stability.

• Diseases such as foot and mouth disease, brucellosis, lumpy skin disease, and avian influenza are reinforcing the need for structured immunization programmes because they can sharply lower productivity, increase mortality, disrupt trade, and weaken the economics of livestock and poultry rearing across multiple states.

• Veterinary authorities and farmers are also increasingly recognizing that immunization not only protects animal health but also helps stabilize returns and reduce broader public health risks linked to zoonotic disease exposure. As a result, vaccines are becoming a routine animal healthcare input rather than a seasonal or reactive intervention. For instance, CARE Ratings states that Hester Biosciences has animal vaccine manufacturing capacity of 13.90 billion doses per annum and is among India’s largest poultry vaccine manufacturers as well as the country’s largest producer of PPR and Goat Pox vaccines.

Growing Global Pet Adoption

• The growing culture of pet ownership and more responsible companion animal care is significantly increasing demand in the India animal vaccines market, as dogs and cats are now being managed with a stronger preventive healthcare mindset, especially in urban households with rising spending on veterinary services.

• Routine immunization is no longer viewed only as a response to immediate disease risk, but as a core part of pet wellness alongside regular checkups, nutrition, grooming, and veterinary visits. This shift is helping make companion animal vaccination more recurring, structured, and commercially important in India.

• Demand is also shaped by India’s very large stray dog population, where vaccination plays a critical role in rabies control and broader community health protection. Government-backed sterilisation and immunization rules, along with support from shelters and animal welfare organizations, are widening the base of vaccine deployment beyond owned pets alone.

• As awareness of zoonotic diseases strengthens, organized supply from established animal health companies is improving access, trust, and adoption across both institutional and retail veterinary channels. For instance, Indian Immunologicals says it holds 70 percent share in India’s animal anti-rabies trade market, exports to 50 countries, and pledged 5 lakh doses of veterinary anti-rabies vaccine for free-roaming dogs.

Key Industry and Government Initiatives

• Government programmes and industry initiatives are playing a central role in expanding the India animal vaccines market by making immunization a more organized, institutionalized, and recurring part of livestock and companion animal healthcare rather than an ad hoc response to isolated outbreaks.

• The strongest momentum comes from national disease control programmes designed to vaccinate cattle, buffalo, sheep, goats, and pigs at scale. These programmes create a stable base for vaccine procurement, administration, and monitoring across states while embedding vaccination into routine livestock management practices.

• These initiatives matter not only for disease prevention but also because they directly support productivity improvement, mortality reduction, and farm income stability. At the same time, companion animal immunization is receiving stronger support through rules and welfare frameworks that encourage sterilisation and vaccination of stray dogs.

• Private manufacturers are reinforcing this policy ecosystem through product development, production scale, and distribution reach across poultry, cattle, small ruminants, and pet segments. For instance, the government stated that up to 2024, around 4.4 crore female calves had been cumulatively vaccinated under the national programme and about 82 crore cumulative foot and mouth disease vaccinations had been carried out.

Expansion of Animal Husbandry

• The continued expansion of animal husbandry in India is creating sustained demand for animal vaccines because rising production of milk, meat, and eggs requires farmers to maintain larger, denser, and more commercially managed herds and flocks across livestock and poultry systems.

• As animal numbers increase, biological risk also rises due to dense populations, frequent animal movement, and closer farm-level contact, making preventive vaccination an essential operational practice. In this environment, vaccines are increasingly viewed as a necessary productivity safeguard rather than a discretionary animal healthcare expense.

• Farmers are becoming more aware that disease outbreaks can quickly reduce milk yield, weaken breeding performance, increase mortality, and create significant financial stress. This is making vaccination more deeply embedded in day-to-day livestock management decisions across bovines, poultry, and small ruminant segments in India.

• Demand is further supported by public programmes promoting broad disease coverage and by private manufacturers scaling vaccine supply to meet growing veterinary needs. In this setting, vaccination supports both health protection and output continuity. For instance, the 20th Livestock Census recorded 535.78 million livestock and 851.81 million poultry in India in 2019, highlighting the enormous scale of animal husbandry that makes preventive vaccination increasingly indispensable.

Download Free Sample Report

Key Market Challenges

High Vaccine Storage Costs

• High storage costs represent a significant restraint on the Indian animal vaccine market. Maintaining vaccine efficacy is critically dependent on a consistent cold chain, but the required infrastructure is expensive. In many rural areas, unreliable electricity and frequent power outages threaten the stability of refrigeration. This makes it difficult to store vaccines at the required temperatures, risking spoilage and rendering them ineffective. The cost of backup power solutions like generators or solar-powered refrigerators is often prohibitively high for individual farmers and small veterinary clinics.

• The financial burden of specialized storage facilities further suppresses vaccine demand. Establishing and maintaining cold rooms and dedicated vaccine refrigeration units requires a substantial initial investment and ongoing operational costs. For the millions of small-scale farmers who form the backbone of India's livestock sector, these expenses are often unattainable. This lack of accessible and affordable cold chain infrastructure directly limits the purchase and use of vaccines, creating a major barrier to widespread disease prevention efforts in the country's agricultural heartlands.

Shortage of Skilled Professionals

• A critical shortage of qualified veterinarians and skilled farm workers is hampering the demand for animal vaccines in India. Effective vaccination programs depend on the expertise of trained professionals to ensure proper administration, dosages, and scheduling. Without sufficient access to veterinary guidance, many farmers remain unaware of the importance of vaccinations or lack the knowledge to administer them correctly. This information gap leads to improper handling, reduced vaccine efficacy, and a general reluctance to invest in preventive healthcare for their livestock.

• The scarcity of skilled farm labor also poses a significant challenge, particularly for implementing large-scale vaccination campaigns. Administering vaccines to large herds or flocks is a labor-intensive process that requires trained assistance. Furthermore, the cost associated with hiring veterinary services can be a major financial barrier for small and marginal farmers. This combination of limited professional access and affordability issues directly contributes to lower vaccination rates, hindering efforts to control animal diseases and protect agricultural productivity across India.

Key Market Trends

Government Initiatives

• Proactive government initiatives are a major driver for the Indian animal vaccine market. Through comprehensive disease surveillance, mass vaccination programs, and public awareness campaigns, the government has been instrumental in safeguarding animal health. These concerted efforts, aimed at controlling and eradicating diseases like FMD, directly stimulate demand for vaccines. By prioritizing animal welfare and implementing preventative strategies, these programs create a stable environment for growth in the animal husbandry and veterinary sectors, bolstering the rural economy and ensuring a secure food supply chain.

• The government's commitment extends to fostering research and innovation in animal healthcare. By investing in modern research facilities and promoting collaboration between academia, industry, and state agencies, India is cultivating an ecosystem for advanced veterinary science. This focus on technological adoption and skill development has improved the quality of animal care and positioned India as an emerging leader in the global veterinary market. These advancements attract investment, generate employment, and drive the socio-economic development of the nation's agricultural sector.

Technological Advancements

• Recent technological advancements are revolutionizing the animal vaccine market by enabling the development of more efficient and targeted vaccines. Innovations using artificial intelligence (AI) and big data analytics are accelerating research and development, significantly improving vaccine efficacy. By analyzing vast datasets on pathogens and immune responses, scientists can design next-generation vaccines faster than ever before. This technological leap is ushering in a new era of proactive disease prevention, protecting animal populations from both existing and emerging health threats.

• The impact of this accelerated vaccine development is profound, allowing for rapid responses to disease outbreaks and strengthening public health security. The ability to create and deploy highly effective vaccines quickly helps contain the spread of infectious diseases, including those with zoonotic potential. This paradigm shift empowers veterinary systems to manage health crises more effectively and protect the agricultural economy from the devastating impact of animal pandemics. As these technologies mature, they promise a future of enhanced global health and more resilient food systems.

Segmental Insights

Animal Type Insights

• The poultry segment is projected to dominate the Indian animal vaccine market, driven by the nation's substantial and growing consumption of poultry products. As an essential source of protein for a large population, poultry flocks' health is directly linked to food safety and public health. The rapid, exponential growth of the poultry industry to meet this rising demand amplifies the need for effective vaccination programs. Consequently, disease prevention in this sector is not merely an agricultural priority but a critical component of national food security.

• This market leadership is also supported by a notable increase in health awareness among poultry farmers. Modern producers understand that proactive, preventive healthcare is essential for maintaining flock productivity and ensuring profitability. They are actively seeking reliable vaccines to protect their birds from costly diseases, viewing vaccination as a crucial investment in their business's sustainability. This combination of high consumption, industry growth, and farmer awareness creates sustained, robust demand for advanced poultry vaccines in the Indian market.

Technology Insights

• In terms of technology, recombinant vaccines are poised to lead the Indian market due to their superior design and efficacy. This advanced technology uses recombinant DNA to introduce one or more specific genes into an animal's cells, thereby stimulating a stronger, more targeted immune response. This precision enables the creation of vaccines that are highly effective against specific pathogens. As a result of this well-defined, controlled development process, recombinant vaccines offer greater efficiency and a safer profile than traditional vaccines.

• The growing preference for recombinant vaccines among veterinarians is a key factor in their projected market dominance. Professionals are increasingly opting for these solutions due to their reliability and reduced risk of side effects. This trend is amplified by the rising prevalence of complex animal diseases and a greater public understanding of animal health needs. As demand for high-quality veterinary care increases with pet ownership and livestock intensification, recombinant vaccines provide an innovative and effective tool to enhance animal welfare and disease control.

Download Free Sample Report

Regional Insights

The North region of India is poised to dominate the national animal vaccine market, a leadership position attributed to its significant concentration of livestock and poultry farms. States in this region have a deep-rooted agricultural history, supporting a thriving industry where animal health is paramount. The high density of animal populations creates a substantial and consistent demand for vaccines to prevent and control disease outbreaks. This established agricultural infrastructure makes North India a critical hub for vaccine consumption and market growth.

A growing awareness among farmers and animal health professionals regarding the importance of vaccination further solidifies North India's market lead. Farmers increasingly view vaccines not as a cost but as a crucial investment for protecting animal health, boosting productivity, and ensuring farm profitability. This change is driven by educational initiatives and active promotion by veterinarians who emphasize the economic benefits of preventive healthcare, leading to higher adoption rates for vaccination protocols across the region.

The rising consumer demand for animal-derived food products like meat and milk also fuels the need for effective vaccines in North India. As the population's dietary preferences evolve, farmers must maintain healthy and productive livestock to meet this demand sustainably. Vaccination is essential for ensuring animals meet the stringent quality and safety standards required for food production. This market pull ensures a steady demand for vaccines, cementing the region's role in the future of India's animal health industry.

Recent Developments

• In February 2025, Bharat Biotech group company Biovet received CDSCO approval for BIOLUMPIVAXIN, a lumpy skin disease vaccine for dairy cattle and buffaloes that was developed in collaboration with the Indian Council of Agricultural Research. News reports described it as the world’s first DIVA marker vaccine for lumpy skin disease, meaning it can help distinguish infected animals from vaccinated ones, which is important for surveillance and eradication programs. The approval was followed by its formal launch in May 2025 at the Livestock Prosperity Conclave in Vijayawada, where Andhra Pradesh Chief Minister N. Chandrababu Naidu highlighted its value for dairy-sector resilience and livestock productivity.

• In June 2025, Boehringer Ingelheim launched a new three-in-one poultry vaccine in India that provides single-dose protection against Bursal, Newcastle, and Marek’s disease. The Hindu BusinessLine reported that the product was positioned as a next-generation solution for broilers, layers, and breeders, designed to improve bird health while reducing the operational burden on farms by consolidating protection into one shot. This launch was notable because it expanded the company’s poultry vaccine portfolio in India with a more efficient format tailored to local farm-management needs.

• In September 2025, leading veterinary vaccine manufacturers including Hester Biosciences, Indian Immunologicals, Biovet, Brilliant Bio Pharma, Globion India, Indovax, and Venkateshwara Hatcheries came together to form the Veterinary Vaccine India Manufacturers Association, or VVIMA. Outlook Business reported that the association was created to act as a collective industry voice and to work with policymakers, regulators, and other stakeholders on innovation, high-quality manufacturing, and global competitiveness in veterinary vaccines. This was a significant collaboration-led development because it moved the sector toward more coordinated policy engagement and a stronger national animal-vaccine ecosystem.

• In September 2025, Indian Immunologicals launched Raksha-IBR, described as India’s first indigenously developed vaccine against infectious bovine rhinotracheitis, during the diamond jubilee celebrations of the National Dairy Development Board in Anand, Gujarat. Deccan Herald reported that the vaccine uses gE-deleted DIVA marker technology, allowing veterinarians to differentiate naturally infected cattle from vaccinated animals, which is a major step forward for disease control in the dairy sector. The launch stood out as a breakthrough innovation because IBR has been a long-standing cause of infertility, abortions, and milk-production losses in cattle, and India previously lacked a domestically developed vaccine for it.

Key Market Players

• Biovet Private Ltd.
• Hester Biosciences Limited
• Intervet India Private Limited(Merck Limited)
• Indovax Pvt. Ltd
• Bio-Med (P) Limited
• Zoetis India Ltd.
• Brilliant Bio Pharma Private Limited
• Virbac Animal Health India Pvt Ltd
• Elanco India Private Limited
• Ceva Polychem Private Limited

Report Scope:

In this report, the India Animal Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Animal Vaccine Market, By Animal Type:

o   Livestock

o   Swine

o   Poultry

o   Companion Animals

o   Others

• India Animal Vaccine Market, By Technology:

o   Inactive Vaccine

o   Live Attenuated Vaccine

o   Toxoid Vaccine

o   Recombinant Vaccine

o   Others

• India Animal Vaccine Market, By Disease:

o   Foot and Mouth Disease

o   New Castle Disease

o   Infectious Bronchitis

o   Infectious Bursal Disease

o   Fowl pox

o   Rabies

o   Others

• India Animal Vaccine Market, By Route of Administration:

o   Subcutaneous

o   Intramuscular

o   Intraocular

o   Oral

o   Others

• India Animal Vaccine Market, By Distribution Channel:

o   Veterinary Hospitals

o   Veterinary Clinics

o   Pharmacies

•  India Animal Vaccine Market, By Region:

o   North

o   South

o   West

o   East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Animal Vaccine Market.

Available Customizations:

India Animal Vaccine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India Animal Vaccine Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]